Banana as Edible Vaccine Asgainst Hepatitis-B: A Theoretical Model
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry · 21.12.2016 · 16 (2) · 129-133
DOI: 10.2174/1871522216666160720101426 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry, erschienen am 21.12.2016. Verfasst von Ankita Maji und 3 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Background: Hepatitis B is a disease which has caused major loss of life over the years. The treatment for the disease is very expensive and cure rate is less. Due to its high cost developing or underdeveloped countries are far out of reach from treatment to hepatitis B. There are vaccines produced against this disease but its cost has limited the use by the masses. In the recent years the plant based vaccines called edible vaccines which are cheap compared to the traditional vaccines have been current area of research. Keywords: Banana, edible vaccine, genetic engineering, Hepatitis B, pBIN19, r-DNA technology.
Zitieren
APA
Maji, A., M., S., Srinivasan, V. M., & Devi, C. S. (2016). Banana as Edible Vaccine Asgainst Hepatitis-B: A Theoretical Model. Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry, 16(2), 129-133. https://doi.org/10.2174/1871522216666160720101426
Vancouver
Maji A, M. S, Srinivasan VM, Devi CS. Banana as Edible Vaccine Asgainst Hepatitis-B: A Theoretical Model. Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry. 2016;16(2):129-133. doi:10.2174/1871522216666160720101426
BibTeX
@article{Maji2016,
author = {Maji, Ankita and M., Sachin and Srinivasan, V. Mohana and Devi, C. Subathra},
title = {Banana as Edible Vaccine Asgainst Hepatitis-B: A Theoretical Model},
journal = {Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry},
year = {2016},
volume = {16},
number = {2},
pages = {129--133},
doi = {10.2174/1871522216666160720101426}
}
EUVIMED